The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo.
Open accessAbstract
The role of prostaglandin E2 (PGE2) in the development of inflammatory symptoms and cytokine production was evaluated in vivo using a neutralizing anti-PGE2 monoclonal antibody 2B5. In carrageenan-induced paw inflammation, pretreatment of rats with 2B5 substantially prevented the development of tissue edema and hyperalgesia in affected paws. The antibody was shown to bind the majority of PGE2 produced at the inflammatory site. In adjuvant-induced arthritis, the therapeutic administration of 2B5 to arthritic rats substantially reversed edema in affected paws. Anti-PGE2 treatment also reduced paw levels of IL-6 RNA and serum IL-6 protein without modifying tumor necrosis factor RNA levels in the same tissue. In each model, the antiinflammatory efficacy of 2B5 was indistinguishable from that of the nonsteroidal antiinflammatory drug indomethacin, which blocked the production of all PGs. These results indicate that PGE2 plays a major role in tissue edema, hyperalgesia, and IL-6 production at sites of inflammation, and they suggest that selective pharmacologic modulation of PGE2 synthesis or activity may provide a useful means of mitigating the symptoms of inflammatory disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs
Winter, C. A., Risley, E. A., & Nuss, G. W. (1962) · Experimental Biology and Medicine · doi:10.3181/00379727-111-27849 · Cited by 5,688
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
Needleman, P., Truk, J., Jakschik, B. A., Morrison, A. R., & Lefkowith, J. B. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.000441 · Cited by 1,807
Coleman, R. A., Smith, W. L., & Narumiya, S. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06784-5 · Cited by 1,735
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551
Self-citationSelective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310
Self-citationThe eicosanoids and their biochemical mechanisms of action
Smith, W. L. (1989) · Biochemical Journal · doi:10.1042/bj2590315 · Cited by 871
Prostaglandins, Aspirin-like Drugs and Analgesia
FERREIRA, S. H. (1972) · Nature New Biology · doi:10.1038/newbio240200a0 · Cited by 866
Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression.
Kunkel, S. L., Spengler, M., May, M. A., Spengler, R., Larrick, J., & Remick, D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60727-6 · Cited by 661
Cited by
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,412
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
Jakobsson, P.-J., Thorén, S., Morgenstern, R., & Samuelsson, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7220 · Cited by 996
Wang, D. (2006) · Gut · doi:10.1136/gut.2004.047100 · Cited by 899
Hata, A. N., & Breyer, R. M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.003 · Cited by 840
Pharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807
Self-citationBagga, D., Wang, L., Farias-Eisner, R., Glaspy, J. A., & Reddy, S. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0334211100 · Cited by 638
Hypernociceptive role of cytokines and chemokines: Targets for analgesic drug development?
Verri, W. A., Cunha, T. M., Parada, C. A., Poole, S., Cunha, F. Q., & Ferreira, S. H. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.001 · Cited by 542
dos Santos, M. D., Almeida, M. C., Lopes, N. P., & de Souza, G. E. P. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.2236 · Cited by 511
A Nonpeptidyl Mimic of Superoxide Dismutase with Therapeutic Activity in Rats
Salvemini, D., Wang, Z.-Q., Zweier, J. L., Samouilov, A., Macarthur, H., Misko, T. P., Currie, M. G., Cuzzocrea, S., Sikorski, J. A., & Riley, D. P. (1999) · Science · doi:10.1126/science.286.5438.304 · Cited by 502
Patrick, R. P., & Ames, B. N. (2015) · The FASEB Journal · doi:10.1096/fj.14-268342 · Cited by 491
Role and regulation of cyclooxygenase-2 during inflammation
Simon, L. S. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00115-1 · Cited by 474
The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis
McCoy, J. M., Wicks, J. R., & Audoly, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15528 · Cited by 352
Murakami, M., Nakashima, K., Kamei, D., Masuda, S., Ishikawa, Y., Ishii, T., Ohmiya, Y., Watanabe, K., & Kudo, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305108200 · Cited by 344
Wang, J. L., Limburg, D., Graneto, M. J., Springer, J., Hamper, J. R. B., Liao, S., Pawlitz, J. L., Kurumbail, R. G., Maziasz, T., Talley, J. J., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.054 · Cited by 337
Mechanical loading, cartilage degradation, and arthritis
Sun, H. B. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05808.x · Cited by 335
Distribution and regulation of cyclooxygenase‐2 in carrageenan‐induced inflammation
Nantel, F., Denis, D., Gordon, R., Northey, A., Cirino, M., Metters, K. M., & Chan, C. C. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702866 · Cited by 333
Cyclooxygenase-2 and prostaglandins in articular tissues
Martel-Pelletier, J., Pelletier, J.-P., & Fahmi, H. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(03)00134-3 · Cited by 333
The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis
McCoy, J. M., Wicks, J. R., & Audoly, L. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215528 · Cited by 320
Docosahexaenoic Acid (DHA): An Ancient Nutrient for the Modern Human Brain
Bradbury, J. (2011) · Nutrients · doi:10.3390/nu3050529 · Cited by 312
Boswellia serrata: An Overall Assessment of In Vitro, Preclinical, Pharmacokinetic and Clinical Data
Abdel-Tawab, M., Werz, O., & Schubert-Zsilavecz, M. (2011) · Clinical Pharmacokinetics · doi:10.2165/11586800-000000000-00000 · Cited by 311
Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
Crofford, L. J., Lipsky, P. E., Brooks, P., Abramson, S. B., Simon, L. S., & Van De Putte, L. B. A. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<4::aid-anr2>3.0.co;2-v · Cited by 296
Pethő, G., & Reeh, P. W. (2012) · Physiological Reviews · doi:10.1152/physrev.00048.2010 · Cited by 288
Cyclooxygenases and the Central Nervous System
Kaufmann, W. E., Andreasson, K. I., Isakson, P. C., & Worley, P. F. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00128-7 · Cited by 285
Self-citationRapid development of colitis in NSAID-treated IL-10–deficient mice
Berg, D. J., Zhang, J., Weinstock, J. V., Ismail, H. F., Earle, K. A., Alila, H., Pamukcu, R., Moore, S., & Lynch, R. G. (2002) · Gastroenterology · doi:10.1053/gast.2002.1231527 · Cited by 279
Reduced Pain Hypersensitivity and Inflammation in Mice Lacking Microsomal Prostaglandin E Synthase-1
Kamei, D., Yamakawa, K., Takegoshi, Y., Mikami-Nakanishi, M., Nakatani, Y., Oh-ishi, S., Yasui, H., Azuma, Y., Hirasawa, N., Ohuchi, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400199200 · Cited by 279
Rieser, C., Böck, G., Klocker, H., Bartsch, G., & Thurnher, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1603 · Cited by 274
Stichtenoth, D. O., Thorén, S., Bian, H., Peters-Golden, M., Jakobsson, P.-J., & Crofford, L. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.469 · Cited by 269
Prostanoid production via COX-2 as a causative mechanism of rodent postoperative ileus
Schwarz, N. T., Kalff, J. C., Türler, A., Engel, B. M., Watkins, S. C., Billiar, T. R., & Bauer, A. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.29605 · Cited by 257
Passos, G. F., Fernandes, E. S., da Cunha, F. M., Ferreira, J., Pianowski, L. F., Campos, M. M., & Calixto, J. B. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.09.032 · Cited by 250
Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain
Trang, T., Beggs, S., & Salter, M. W. (2011) · Neuron Glia Biology · doi:10.1017/s1740925x12000087 · Cited by 197
Inflammatory cytokine-associated depression
Lotrich, F. E. (2015) · Brain Research · doi:10.1016/j.brainres.2014.06.032 · Cited by 183
Holt, S., Comelli, F., Costa, B., & Fowler, C. J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706348 · Cited by 168
“Thus, for example, i.p. pretreatment of rats with a neutralising monoclonal antibody against prostaglandin E2 (PGE2) reduces carrageenan induced oedema to the level seen following indomethacin (30mg kg 1 p.o.) treatment (Portanova et al., 1996).”
BackgroundP2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release
Barberà‐Cremades, M., Baroja‐Mazo, A., Gomez, A. I., Machado, F., Di Virgilio, F., & Pelegrín, P. (2012) · The FASEB Journal · doi:10.1096/fj.12-205765 · Cited by 142
Cyclooxygenase Inhibition as a Strategy to Ameliorate Brain Injury
Hurley, S. D., Olschowka, J. A., & O'Banion, M. K. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753460196 · Cited by 110
Sandulache, V. C., Parekh, A., Li‐Korotky, H., Dohar, J. E., & Hebda, P. A. (2007) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2006.00193.x · Cited by 91
Metadata
- Authors
- Portanova, J. P., Zhang, Y., Anderson, G. D., Hauser, S. D., Masferrer, J. L., Seibert, K., Gregory, S. A., & Isakson, P. C.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-09-01
- Volume
- 184
- Issue
- 3
- Pages
- 883-891
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2113683216
- Cited by
- 421
- References
- 27
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.